Effectiveness of Dupilumab Treatment in Patients With Type 2 Inflammation: A Real-Life Integrated Experience [0.03%]
Dupilumab治疗2型炎症患者的疗效：真实世界中的综合经验
Sara Torretta,Gioia Piatti,Chiara Catalano et al.
Sara Torretta et al.
Background: Type 2 inflammation plays a pivotal role in various allergic and inflammatory diseases, including chronic rhinosinusitis, asthma, atopic dermatitis, and eosinophilic esophagitis. Dupilumab is one of the emergi...
Outcomes of Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyposis and Risk Factors of Recurrence in a Tertiary Care Teaching Hospital [0.03%]
三级医疗教学医院慢性鼻窦炎和鼻息肉内窥镜鼻窦手术的预后及其复发的风险因素
Ahmad Aldajani,Ahmad Alroqi,Ali Alrashidi et al.
Ahmad Aldajani et al.
Background: Endoscopic sinus surgery (ESS) has become the gold standard for treating patients with chronic rhinosinusitis (CRS) refractory to medical therapy. It is considered a relatively safe and effective procedure in ...
Acute Vision Loss in Patients With Allergic Fungal Rhinosinusitis: A Case Series [0.03%]
过敏性真菌性鼻窦炎患者急性视力下降的病例系列研究报告
Hussain Allami,Hadeel Muhammad Alarfaj,Hisham Almousa et al.
Hussain Allami et al.
Allergic fungal rhinosinusitis (AFRS) is a subtype of chronic noninvasive sinusitis accounting for 7.8% (0.2%-26.7%) of all chronic rhinosinusitis cases. A definitive diagnosis is usually made after sinus surgery. Successful treatment requi...
Central Compartment Atopic Disease and Its Surgical Outcomes: Olfactory Changes and Technical Notes [0.03%]
中央型过敏性疾病及其手术结局：嗅觉改变和技术细节注释
Sheng-Kai Huang,Ching-Hung Hsieh,Ming-Chian Weng et al.
Sheng-Kai Huang et al.
Background: Central compartment atopic disease (CCAD) is a recent, novel phenotype of chronic rhinosinusitis. Only a few studies have assessed olfactory function in patients with CCAD. ...
CD5 B-Cell Predominant Primary Immunodeficiency: Part of the Spectrum of MAGT1 Deficiency [0.03%]
CD5B细胞为主的原发性免疫缺陷病：MAGT1缺陷谱系的一部分
Marija J Rowane,Benjamin C Stewart-Bates,Rayna J Doll et al.
Marija J Rowane et al.
Background: Selective anti-polysaccharide antibody deficiency (SPAD) with CD5 B-cell predominance and autoimmune phenomena was identified in a male cohort first reported by Antall et al in 1999. The phenotypically likewis...
Loss of Vision Outcome for Allergic Fungal Sinusitis: Case Report and Literature Review [0.03%]
过敏性真菌性鼻窦炎失明一例及文献复习
Ahmed Alhussien,Abdulrahman Alghulikah,Hussain Albaharna et al.
Ahmed Alhussien et al.
Visual loss is a rare manifestation of allergic fungal rhinosinusitis (AFRS). We report a case of an adult male who was diagnosed with AFRS and who presented during the COVID-19 pandemic lockdown with sudden-onset complete vision loss and a...
COVID-19 Incidence and Disease Course Among Patients at an Allergy Department [0.03%]
过敏科患者的新型冠状病毒肺炎发病率及疾病病程
Louise E van der Aa,Inge S van Egmond,Martijn van der Sluijs et al.
Louise E van der Aa et al.
Background: Since the coronavirus pandemic in 2020, there is not much reported about the disease course of COVID-19 in patients with allergic diseases. Ob...
Association of ANRIL Gene Single-Nucleotide Polymorphisms With Allergic Rhinitis in Kurdish Population From Kermanshah, Iran [0.03%]
ANRIL基因单核苷酸多态性与伊朗克尔曼沙阿库尔德人群过敏性鼻炎的关系
Sara Falahi,Parisa Feizolahi,Ali Monshizadeh et al.
Sara Falahi et al.
Background: Allergic rhinitis (AR) is the most common inflammatory disorder of the upper airway caused by aberrant immune responses to allergens in genetically predisposed individuals. Recently, the long noncoding RNA (ln...
Nasal Cavity Length or Analyzed Nasal Segment of Acoustic Rhinometry in Thai Adults [0.03%]
泰國成年人的鼻腔長度或聲阻式鼻咽計測段分析
Paraya Assanasen,Triphoom Suwanwech,Bannapuch Pinkaew et al.
Paraya Assanasen et al.
Background: Nasal cavity length (NCL) is important for determining analyzed nasal segment (ANS) of acoustic rhinometry (AR). AR is a technique for nasal airway assessment which nasal cross-sectional areas and nasal volume...
Epinephrine Administered in Anaphylaxis: The Evolution of 0.3 mg Dosage [0.03%]
抢救过敏反应的肾上腺素注射剂量的变化趋势——0.3mg剂量的演变过程分析
Peyton Coady,Kenneth L Dretchen,Michael Mesa
Peyton Coady
Background: Despite epinephrine's historical use for over a century and Food and Drug Administration (FDA) approval for EpiPen's use in 1987 to treat anaphylaxis, little information exists regarding selection of the 0.3 m...